Related Experiment Video
Updated: Jun 28, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Discovery of new Mycoplasma pneumoniae antigens by use of a whole-genome lambda display library
Elisa Beghetto1, Francesca De Paolis, Francesca Montagnani
1Kenton laboratories, Kenton S.r.l., Rome, Italy.
Abstract:
Mycoplasma pneumoniae is the leading cause of atypical pneumonia in children and young adults. Bacterial colonization can occur in both the upper and the lower respiratory tracts and take place both endemically and epidemically worldwide. Characteristically, the infection is chronic in onset and recovery and both humoral and cell-mediated mechanisms are involved in the response to bacterial colonization. To identify bacterial proteins recognized by host antibody responses, a whole-genome M. pneumoniae library was created and displayed on lambda bacteriophage. The challenge of such a library with sera from individuals hospitalized for mycoplasmal pneumonia allowed the identification of a panel of recombinant bacteriophages carrying B-cell epitopes. Among the already known M. pneumoniae B-cell antigens, our results confirmed the immunogenicity of P1 and P30 adhesins. Also, the data presented in this study localized, within their sequences, the immunodominant epitopes recognized by human immunoglobulins. Furthermore, library screening allowed the identification of four novel immunogenic polypeptides, respectively, encoded by fragments of the MPN152, MPN426, MPN456 and MPN-500 open reading frames, highlighting and further confirming the potential of lambda display technology in antigen and epitope discovery.
Insights
This study identified novel Mycoplasma pneumoniae antigens. Researchers used lambda display technology to find bacterial proteins recognized by antibodies, aiding in understanding atypical pneumonia.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Mycoplasma pneumoniae causes atypical pneumonia globally in children and young adults.
- Infection involves chronic onset and recovery, with both humoral and cell-mediated immune responses.
- Identifying specific bacterial antigens is crucial for understanding host-pathogen interactions.
Purpose of the Study:
- To identify bacterial proteins recognized by host antibody responses in Mycoplasma pneumoniae infections.
- To discover novel immunogenic polypeptides and map epitopes targeted by human antibodies.
- To validate lambda display technology for antigen and epitope discovery.
Main Methods:
- Construction and screening of a whole-genome Mycoplasma pneumoniae library displayed on lambda bacteriophage.
- Incubation of the library with sera from patients hospitalized with mycoplasmal pneumonia.
- Identification of recombinant bacteriophages displaying B-cell epitopes.
Main Results:
- Confirmed the immunogenicity of known Mycoplasma pneumoniae antigens, P1 and P30 adhesins.
- Localized immunodominant epitopes recognized by human immunoglobulins within antigen sequences.
- Identified four novel immunogenic polypeptides encoded by MPN152, MPN426, MPN456, and MPN-500 open reading frames.
Conclusions:
- Lambda display technology is effective for identifying Mycoplasma pneumoniae antigens and epitopes.
- The study identified novel immunogenic targets, advancing the understanding of Mycoplasma pneumoniae pathogenesis.
- Findings contribute to the potential development of new diagnostic or therapeutic strategies.
Related Concept Videos
Modern Molecular Taxonomy
Atypical Pneumonia
